Kailera Therapeutics, Inc.(KLRA)
Biotechnology
Neuroscience Biotech
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-04-22 | RTW INVESTMENTS, LP 10% Owner | Purchase | +500,000 | +4.87%10,776,820 | $16.00 | $8,000,000 | View SEC filing | |
| 2026-04-20 | BAIN CAPITAL INVESTORS LLC 10% Owner | Purchase | +8,398,438 | +47.03%26,255,581 | $16.00 | $134,375,008 | View SEC filing | |
| 2026-04-20 | Koppel Adam Director, 10% Owner | Purchase | +1,562,500 | +7.43%22,583,268 | $16.00 | $25,000,000 | View SEC filing | |
| 2026-04-20 | Bain Capital Life Sciences Investors, LLC 10% Owner | Purchase | +1,562,500 | +7.43%22,583,268 | $16.00 | $25,000,000 | View SEC filing | |
| 2026-04-20 | Kaplan Andrew T. Director, 10% Owner | Purchase | +8,398,438 | +47.03%26,255,581 | $16.00 | $134,375,008 | View SEC filing |
1-5 of 5